The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 16 - 2025 |
doi: 10.3389/fmicb.2025.1508941
This article is part of the Research Topic Opportunistic pathogens: pathogenesis and multi-drug resistance mechanisms View all 8 articles
Multidrug Resistance of Pseudomonas aeruginosa: Do Virulence Properties Impact on Resistance Pattern?
Provisionally accepted- 1 University of Dhaka, Dhaka, Bangladesh
- 2 Dhaka Medical College and Hospital, Dhaka, Dhaka, Bangladesh
Patients with nosocomial infections are at risk of multidrug resistant (MDR) Pseudomonas aeruginosa since these bacteria slow down the entire treatment process, increasing the morbidity and mortality of patients staying in hospital. The purpose of the research was to assess the simultaneous presence of multidrug resistance and virulence factors among nosocomial strains of P. aeruginosa for evaluating significant association among them. . One hundred and eight clinical isolates of P. aeruginosa were found in a variety of samples taken from patients having nosocomial infection, including wound swabs, pus, sputum, tracheal aspirate, and urine. An antibiogram was performed to investigate the pathogen's antibiotic sensitivity pattern against 14 widely used antibiotics in Bangladesh. Virulence factors were evaluated and the presence of ten β-lactamase and six virulence genes were analyzed by performing PCR. By employing binary logistic regression test maintaining a 95% confidence interval, the relationship between MDR phenotypes and the virulence attributes was assessed. The susceptibility rate among the isolates was 70-75% for aminoglycosides (amikacin, gentamicin, netilmicin), 15-20% for cephalosporins (ceftazidime, ceftriaxone), 30-35% for quinolones (ciprofloxacin, levofloxacin), 10-15% for tetracyclines (tigecycline, doxycycline), 15-20% for carbapenem (meropenem), 10-15% for sulfonamide (co-trimoxazole), 5-10% for amoxiclav and 30-35% for piperacillin/ tazobactam. 74.1% of the strains carried metallo-β-lactamase (MBL) genes. Among the isolates 89% showed hemolytic activity, 80-90% produced different pigments like fluorescein and pyoverdine, 46% were strong biofilm producers and all the isolates presented different types of motility (swimming, swarming and twitching). The virulence genes (lasB, exoS, toxA, aprA, algD, and plcH) were detected within a range of 60-80% of the isolates. Only toxA gene and twitching motility showed significant correlation (p-value 0.001 and 0.028, respectively) with multidrug resistance in the clinical P. aeruginosa isolates which indicates that it can be used as a drug target to combat these organisms. High prevalence of MDR strains and their association with virulence factors revealed the potential of the pathogen to cause an infection. The current study advocates for immediate epidemiological surveillance of MDR P. aeruginosa strains in Bangladesh to impede the rapid dissemination of this opportunistic pathogen.
Keywords: multidrug resistance, Virulence properties, P. aeruginosa, Nosocomial infection, -lactamase
Received: 10 Oct 2024; Accepted: 13 Jan 2025.
Copyright: © 2025 Saha, Kabir, Ahsan and Yasmin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mahmuda Yasmin, University of Dhaka, Dhaka, Bangladesh
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.